EGFR and neoplasm: Beside simply relying on the enhanced permeability and retention (EPR) effect for tumor passive tumor, the well-engineered phototherapeutic nanoagents were conjugated with targeting ligands, including anti-epidermal growth factor receptor (EGFR) antibody, to selectively target tumor via active tumor homing [29].